发明名称 |
N- (6- ( (2R,3S) -3,4-Dihydroxybutan-2-yloxy) -2- (4 - fluorobenzylthio) pyrimidin- 4 - yl) -3- methylazetidine- 1 - sulfonamide as chemokine receptor modulator |
摘要 |
There is provided a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, processes for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound, and pharmaceutical compositions containing the compound. The compound is useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial. |
申请公布号 |
AU2012282316(A1) |
申请公布日期 |
2013.05.02 |
申请号 |
AU20120282316 |
申请日期 |
2012.07.10 |
申请人 |
ASTRAZENECA AB |
发明人 |
CONNOLLY, STEPHEN;EBDEN, MARK RICHARD;LANGER, THOMAS;STEVEN, ALAN ROBERT;STEWART, CRAIG ROBERT;TOMLIN, PAULA MARGARET;WALTERS, IAIN ALASTAIR STEWART;WILLIAMS, ANDREW JOHN |
分类号 |
C07D403/12;A61K31/506;C07C69/92;C07D205/04;C07D317/20;C07D317/24 |
主分类号 |
C07D403/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|